Breaking News, Promotions & Moves

Biocon Names Shreehas Tambe CEO and Managing Director

Tambe becomes the first CEO of Biocon Limited following the full integration of Biocon Biologics as its wholly owned subsidiary.

Author Image

By: Patrick Lavery

Content Marketing Editor

Biocon is appointing Shreehas Tambe as Chief Executive Officer (CEO) and Managing Director effective April 1, 2026. Tambe is the first CEO of Biocon Limited, following the full integration of Biocon Biologics as its wholly owned subsidiary. In its revamped structure, Biocon’s portfolio includes biosimilars, insulins, complex generics, and peptides, spanning diabetes, obesity, oncology, and immunology. An Experienced CEO and Managing Director Despite the new appointment, Tambe is not new...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters